ZA200711068B - Injectable compositions and process for preparation of such compositions - Google Patents

Injectable compositions and process for preparation of such compositions

Info

Publication number
ZA200711068B
ZA200711068B ZA200711068A ZA200711068A ZA200711068B ZA 200711068 B ZA200711068 B ZA 200711068B ZA 200711068 A ZA200711068 A ZA 200711068A ZA 200711068 A ZA200711068 A ZA 200711068A ZA 200711068 B ZA200711068 B ZA 200711068B
Authority
ZA
South Africa
Prior art keywords
compositions
preparation
injectable
injectable compositions
Prior art date
Application number
ZA200711068A
Other languages
English (en)
Inventor
Jain Rajesh
Jindal Kour Chand
Singh Sukhjeet
Boldhane Sanjay
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of ZA200711068B publication Critical patent/ZA200711068B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200711068A 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions ZA200711068B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1357DE2005 2005-05-27

Publications (1)

Publication Number Publication Date
ZA200711068B true ZA200711068B (en) 2009-03-25

Family

ID=36917368

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200711068A ZA200711068B (en) 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions

Country Status (15)

Country Link
EP (1) EP1895983A2 (xx)
JP (1) JP2008542260A (xx)
KR (1) KR20080016689A (xx)
CN (1) CN101217939A (xx)
AU (1) AU2006250765A1 (xx)
BR (1) BRPI0611170A2 (xx)
CA (1) CA2609242A1 (xx)
CR (1) CR9616A (xx)
EA (1) EA200702646A1 (xx)
MX (1) MX2007014862A (xx)
NO (1) NO20076468L (xx)
RS (1) RS20070461A (xx)
TN (1) TNSN07482A1 (xx)
WO (1) WO2006126214A2 (xx)
ZA (1) ZA200711068B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
ES2823249T3 (es) 2009-03-12 2021-05-06 Cumberland Pharmaceuticals Inc Administración de ibuprofeno por vía intravenosa
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102335114B (zh) * 2010-07-23 2015-07-15 重庆医药工业研究院有限责任公司 一种稳定的布洛芬精氨酸注射剂及其制备方法
CN102370615B (zh) * 2010-08-19 2013-09-04 四川科伦药物研究有限公司 一种布洛芬注射制剂及其制备方法
ES2859676T3 (es) 2011-10-18 2021-10-04 Askat Inc Composición medicinal
CN102512383A (zh) * 2011-12-25 2012-06-27 天津市嵩锐医药科技有限公司 供注射用的帕瑞昔布钠药物组合物
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN103372216B (zh) * 2012-04-26 2015-05-06 北京京卫燕康药物研究所有限公司 一种含有塞来昔布的固体药物组合物
TWI646091B (zh) 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103263385B (zh) * 2013-05-17 2016-04-27 江苏正大清江制药有限公司 一种塞来昔布长效纳米注射剂及其制备方法
PE20171305A1 (es) * 2014-12-20 2017-09-05 Troikaa Pharmaceuticals Ltd Formulaciones inyectables de paracetamol
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
CN107303266B (zh) * 2016-04-18 2020-09-08 重庆润泽医药有限公司 左旋奥拉西坦注射液及其制备方法
CN107303264A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 无泡沫左旋奥拉西坦注射液及其制备方法
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
CN111103381A (zh) * 2019-12-25 2020-05-05 南京希麦迪医药科技有限公司 一种液质联用测定人血浆中尼美舒利浓度的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
IN187306B (xx) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
US7695736B2 (en) * 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
AU2003249510A1 (en) * 2002-08-12 2004-02-25 Ranbaxy Laboratories Limited A parenteral dosage form of selective cox-2 inhibitors

Also Published As

Publication number Publication date
NO20076468L (no) 2008-02-27
MX2007014862A (es) 2008-02-21
WO2006126214A3 (en) 2007-06-07
RS20070461A (xx) 2008-11-28
EA200702646A1 (ru) 2008-06-30
AU2006250765A1 (en) 2006-11-30
WO2006126214A2 (en) 2006-11-30
CN101217939A (zh) 2008-07-09
TNSN07482A1 (fr) 2009-03-17
KR20080016689A (ko) 2008-02-21
JP2008542260A (ja) 2008-11-27
CA2609242A1 (en) 2006-11-30
BRPI0611170A2 (pt) 2010-08-17
CR9616A (es) 2008-10-30
EP1895983A2 (en) 2008-03-12

Similar Documents

Publication Publication Date Title
ZA200711068B (en) Injectable compositions and process for preparation of such compositions
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
IL179627A0 (en) Particulate-stabilized injectable pharmaceutical compositions of posaconasole
ZA200707831B (en) Tigecycline compositions and methods of preparation
EP1938842A4 (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION COMPRISING IMPROVED CRASHING CHARACTERISTICS
GB0706778D0 (en) Compositions and methods for producing fementation products and residuals
IL192098A (en) Preparations and Methods for Manufacturing Preparations
IL196465A0 (en) Compositions and methods for the treatment of mucositis
GB0521708D0 (en) Method of preparing a pharmaceutical composition and pharmaceutical compositions obtainable thereby
IL198847A (en) Process for making 2-imino-thiazolidine-4-on and several such histories
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
IL195761A0 (en) Compositions and methods relating to novel compounds and targets thereof
GB0519347D0 (en) Composition of enhanced stability and a process for making such a composition
AP2008004524A0 (en) Terpene-containing compositions and method of making and using them
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
IL189067A0 (en) Compositions and methods for production of immunoglobulins
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
GB0617171D0 (en) Novel compositions and methods
ZA200806434B (en) Calcium-enrichment compositions and methods for production thereof
IL186606A0 (en) Compositions and uses of amooranin compounds
HK1125822A1 (en) Compositions useful for reducing nephrotoxicity and methods of use thereof
IL189177A0 (en) Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide
EP1962882A4 (en) COMPOSITIONS AND METHOD FOR TREATING DIABETES
EP2046109A4 (en) PHOTOSYNTHETIC ORGANISMS, COMPOSITIONS AND METHODS FOR GENERATING THESE ORGANISMS
HU0500947D0 (en) Composition for treatment of paradontosis